Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

3.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  3. 研究分野
  5. 生物医学と臨床科学
  7. 心血管医学と血液学
  9. 心臓病 (心血管疾患を含む)
  11. 心不全における免疫線維細胞通信を標的とする

心不全における免疫線維細胞通信を標的とする

Junedh M Amrute1, Xin Luo2, Vinay Penna1

  • 1Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.

Nature
|October 24, 2024

関連する実験動画

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.0K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.2K
Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts
07:10

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts

Published on: May 16, 2021

4.6K

PubMed で要約を見る

まとめ
この要約は機械生成です。

炎症は特定の線維細胞集団を促すことで心臓線維症を誘発する. 免疫細胞と線維細胞におけるインタールイキン-1β (IL- 1β) 信号をターゲットにすることで,線維症が軽減され,心臓の機能が改善されました.

関連する実験動画

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.0K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.2K
Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts
07:10

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts

Published on: May 16, 2021

4.6K

科学分野:

  • 心血管生物学
  • 免疫学
  • 繊維症の研究

背景:

  • 炎症と組織線維症は,臓器機能障害,特に心臓病に関連しています.
  • ヒトの心臓病における免疫線維芽細胞のコミュニケーションの分子メカニズムは十分に理解されていません.
  • 現在の治療法では心臓線維症を直接対象にしていません.

研究 の 目的:

  • ヒトの心臓病における免疫線維細胞とのコミュニケーションの分子メカニズムを探求する.
  • 心筋線維症の治療標的を特定する

主な方法:

  • マルチオミック単細胞遺伝子発現,エピトープマッピング,ヒト心臓におけるクロマチンのアクセシビリティプロフィール.
  • 生体内での遺伝子の追跡
  • 心臓線維芽細胞モデルのマウスモデルの評価
  • リガンド受容体分析と空間トランスクリプトミクス
  • IL-1βシグナル伝達経路のインビボ操作

主要な成果:

  • 異なったミオフィブロブラストとFAP/POSTN+マトリフィブロサイト集団と関連した線維細胞の軌道を特定した.
  • FAP+ 線維細胞は POSTN 系統に寄与する.
  • In vivo マウスモデルは,培養細胞よりもヒトの心臓線維症をよく再現します.
  • CCR2+マクロファージとフィブロブラストの間のIL-1βシグナル伝達は,FAP/POSTN+フィブロブラストの出現を誘導する.
  • 減少したFAP/ POSTN+線維細胞,心筋線維症,心機能の改善.

結論:

  • インタールイウキン-1β (IL-1β) 信号伝達は,心臓線維症を誘発する免疫線維細胞の重要な媒介である.
  • マクロファージとフィブロブラストのIL-1βシグナル伝達をターゲットにすることで,心臓線維症の治療戦略が提供されます.
  • 炎症を軽減することで臓器の機能が保たれます